Impact of Diabetes and Glucose Control During Rehabilitation After Stroke

Diabetes Clinical Trial

Official title:

Impact of Diabetes and Glucose Control During Rehabilitation After Stroke

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00241956
• Other study ID #: 2004.246
• Status: Terminated
• Phase: N/A
• First received: October 18, 2005
• Last updated: July 19, 2011
• Start date: October 2005
• Est. completion date: May 2006

Study information

• Verified date: July 2011
• Source: Melbourne Health
• Contact: n/a
• Is FDA regulated: No
• Health authority: Australia: Department of Health and Ageing Therapeutic Goods Administration
• Study type: Observational

Clinical Trial Summary

To assess whether patients with diabetes have less clinical improvement during inpatient rehabilitation than those without diabetes and whether hyperglycaemia during rehabilitation is an adverse prognostic indicator.

Description:

Patients with diabetes have a higher mortality rate and more severe disability from stroke compared to those without diabetes. Those with hyperglycaemia tend to progress to a larger final stroke size. Diabetes and hyperglycaemia may affect the ability of the patient to clinically improve, independent of the degree of initial impairment. We will perform a retrospective review of medical records of stroke patients admitted to an inpatient rehabilitation unit. We will compare outcomes of changes in disability scales (FIM and Barthel) from admission to discharge, length of stay and hospital events between those with and without diabetes. Amongst those with diabetes, we will also assess whether those with higher mean blood glucose levels during their inpatient rehabilitation stay have worse outcomes.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 20
• Est. completion date: May 2006
• Est. primary completion date: May 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Inpatient rehabilitation for acute stroke

Exclusion Criteria:

• Medical records unavailable

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Cerebrovascular Accident
• Diabetes
• Hyperglycemia
• Stroke

Locations

Country	Name	City	State
Australia	The Royal Melbourne Hospital	Melbourne	Victoria

Sponsors (2)

Lead Sponsor	Collaborator
Melbourne Health	National Health and Medical Research Council, Australia

Country where clinical trial is conducted

Australia,